AHA: PREVENT risk calculator estimates risk for cardiovascular disease
Nov 13, 2023
PREVENT equations were developed and validated in adults aged 30 to 79 years without known CVD and included eGFR as a predictor.
Nonphysician-implemented multifaceted intervention beneficial in HTN
Jun 20, 2024
Significant reductions were seen in total cardiovascular disease and all-cause mortality for those aged 60 years and older; significant reductions also were seen for those younger than 60 years.
Patterns studied for alcohol intake, outcomes in patients with CVD
Jul 29, 2021
Relative to nondrinkers, a J-shaped curve was seen for all-cause mortality, cardiovascular mortality, and cardiovascular events in drinkers with preexisting cardiovasular disease.
Menopausal hormone therapy use beyond 65 years beneficial
Apr 16, 2024
Use of menopausal hormone therapy beyond age 65 years is associated with risk reductions in mortality as well as specific cancers and cardiovascular diseases, according to a study published online April...